NCT06881823 2025-12-29
NeoPSMA
Novartis
Phase 1/2 Withdrawn
Clinical Trials
9 trialsNCT06218667 2024-10-31
A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Withdrawn
NCT06329830 2024-09-19
LUNAAR
Baptist Health South Florida
Phase 1/2 Withdrawn
NCT03709550 2022-10-05
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Roswell Park Cancer Institute
Phase 1/2 Withdrawn
NCT05191017 2022-08-05
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
Nuvation Bio Inc.
Phase 1/2 Withdrawn
NCT00769990 2017-12-13
Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
Masonic Cancer Center, University of Minnesota
Phase 1/2 Withdrawn
NCT01565512 2015-03-05
Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort
Columbia University
Phase 1/2 Withdrawn
NCT02054793 2014-07-23
Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)
Johns Hopkins University
Phase 1/2 Withdrawn
NCT01153113 2011-12-02
Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines
University of Florida
Phase 1/2 Withdrawn